Mednet Logo

Do you check baseline or surveillance audiometry (if not overtly symptomatic) to screen for hearing loss in all patients getting cisplatin?

Community PollStarted

Do you check baseline audiometry to screen for hearing loss in patients getting cisplatin?

76 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Indiana Univ Simon Cancer Center
Answered on

I disagree. When we started testis studies in 1974 with PVB, we did baseline audiometry and repeated it at 9 weeks, 3 months and 6 months. Everyone experiences a certain degree of high frequency hearing loss which is usually reversible. During the past 40 years we NEVER get baseline audiometry as te...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Virginia
Answered on

Interesting response! (And thanks for the pathophysiology lesson!) We don't get audiometry for our lung cancer patients on cisplatin if they have no hearing complaints prior to therapy. First, they rarely get months and months of treatment, so it rarely is a clinical problem for lung cancer patients...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Stanford University Medical Center
Answered on

Yes. I always initiate a baseline audiometry test in all of my patients initiating cisplatin-based therapy. For each patient on full-dose cisplatin therapy, I then conduct monitoring before each cycle of therapy and follow-up audiometry one month, three months and six months post-therapy. Cisplatin ...

Join for free or sign in to see the full answer